Cardiovascular Risk in Type 1 Diabetes Mellitus

被引:0
作者
Jonathan Schofield
Jan Ho
Handrean Soran
机构
[1] Manchester University Hospitals NHS Foundation Trust,Manchester Diabetes Centre, Manchester Royal Infirmary
[2] Manchester Academic Health Science Centre,Cardiovascular Research Group, Faculty of Biology, Medicine and Health
[3] University of Manchester,Cardiovascular Trials Unit, University Department of Medicine
[4] Manchester University Hospitals NHS Foundation Trust,undefined
[5] Manchester Academic Health Science Centre,undefined
来源
Diabetes Therapy | 2019年 / 10卷
关键词
Cardiovascular disease; Cardiovascular risk; Type 1 diabetes mellitus;
D O I
暂无
中图分类号
学科分类号
摘要
Type 1 diabetes mellitus (T1DM) is associated with premature cardiovascular disease (CVD), but the underlying mechanisms remain poorly understood. The American Diabetes Association and the European Association for the Study of Diabetes recently updated their position statement on the management of type 2 diabetes mellitus (T2DM) to include additional focus on cardiovascular risk; improved management of risk factors in T1DM is also needed. There are important differences in the pathophysiology of CVD in T1DM and T2DM. Hyperglycaemia appears to have a more profound effect on cardiovascular risk in T1DM than T2DM, and other risk factors appear to cause a synergistic rather than additive effect, so achievement of treatment targets for all recognized risk factors is crucial to reducing cardiovascular risk. Here we discuss the evidence for addressing established cardiovascular risk factors, candidate biomarkers and surrogate measurements, and possible interventions.
引用
收藏
页码:773 / 789
页数:16
相关论文
共 404 条
  • [1] Khunti K(2015)Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study Diabetes Care 38 316-322
  • [2] Davies M(2010)Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes Diabetes 59 3216-3222
  • [3] Majeed A(2015)Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis Lancet Diabetes Endocrinol 3 198-206
  • [4] Thorsted BL(2006)High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database Diabetes Care 29 798-804
  • [5] Wolden ML(2014)Glycemic control and excess mortality in type 1 diabetes N Engl J Med 371 1972-1982
  • [6] Paul SK(2007)Progression of coronary artery calcium in type 1 diabetes mellitus Am J Cardiol 100 1543-1547
  • [7] Secrest AM(1987)Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus Br Med J (Clin Res Ed) 294 1648-1651
  • [8] Becker DJ(2018)Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetologia 377 300-301
  • [9] Kelsey SF(2017)Mortality and cardiovascular disease in type 1 and type 2 diabetes N Engl J Med 9 e1001321-2167
  • [10] Laporte RE(2012)Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study PLoS Med 36 2160-2839